News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Joint Venture Between Sanofi Pasteur (SASY.PA), Thailand's Government Pharmaceutical Organization (GPO) Aims for New Vaccine With Fewer Side Effects


11/4/2013 7:51:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A joint venture between Thailand's Government Pharmaceutical Organization (GPO) and France's Sanofi Pasteur is embarking upon a 700-million-baht upgrade to its vaccine production facility here. The expansion at Government Pharmaceutical Organization-Merieux Biological Products Co (GPO-MBP), to begin this year, will take eight years and result in a new combination vaccine with fewer side effects.

Help employers find you! Check out all the jobs and post your resume.

Read at Bangkok Post

comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES